Hospira Precedex injection wins six months pediatric exclusivity in US
Precedex, an alpha-2 agonist, is approved for use only in adults and the US regulator is reviewing its pediatric use. Precedex is indicated for sedation of initially intubated
The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) from Pfizer and Valneva for their Lyme disease vaccine candidate, PF-07307405.